Search company, investor...


Founded Year



Acquired | Acquired

Total Raised


About CodeRyte

CodeRyte sells Web-based software to help hospitals, physician practice groups, and medical billing companies process insurance claims.

Headquarters Location

7500 Old Georgetown Road Suite 800

Bethesda, Maryland, 20814,

United States


Missing: CodeRyte's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: CodeRyte's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing CodeRyte

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned CodeRyte in 1 CB Insights research brief, most recently on Feb 11, 2021.

CodeRyte Frequently Asked Questions (FAQ)

  • When was CodeRyte founded?

    CodeRyte was founded in 1999.

  • Where is CodeRyte's headquarters?

    CodeRyte's headquarters is located at 7500 Old Georgetown Road, Bethesda.

  • What is CodeRyte's latest funding round?

    CodeRyte's latest funding round is Acquired.

  • How much did CodeRyte raise?

    CodeRyte raised a total of $59.2M.

  • Who are the investors of CodeRyte?

    Investors of CodeRyte include 3M, New Vantage Group, Cardinal Partners, Solstice Capital, Polaris Partners and 11 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.